Lloyd A Rowland - Net Worth and Insider Trading
Lloyd A Rowland Net Worth
The estimated net worth of Lloyd A Rowland is at least $187,188 dollars as of 2024-04-28. Lloyd A Rowland is the General Counsel of CytomX Therapeutics Inc and owns about 117,728 shares of CytomX Therapeutics Inc (CTMX) stock worth over $187,188. Details can be seen in Lloyd A Rowland's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lloyd A Rowland has not made any transactions after 2024-03-19 and currently still holds the listed stock(s).
Transaction Summary of Lloyd A Rowland
Lloyd A Rowland Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lloyd A Rowland owns 2 companies in total, including CytomX Therapeutics Inc (CTMX) , and Xencor Inc (XNCR) .
Click here to see the complete history of Lloyd A Rowland’s form 4 insider trades.
Insider Ownership Summary of Lloyd A Rowland
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-03-19 | General Counsel |
| XNCR | Xencor Inc | 2014-08-29 | Sr. V.P. and General Counsel |
Lloyd A Rowland Latest Holdings Summary
Lloyd A Rowland currently owns a total of 1 stock. Lloyd A Rowland owns 117,728 shares of CytomX Therapeutics Inc (CTMX) as of March 19, 2024, with a value of $187,188.
Latest Holdings of Lloyd A Rowland
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-03-19 | 117,728 | 1.59 | 187,188 |
Holding Weightings of Lloyd A Rowland
Lloyd A Rowland Form 4 Trading Tracker
According to the SEC Form 4 filings, Lloyd A Rowland has made a total of 5 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 5,268 shares on March 19, 2024, which brought Lloyd A Rowland around $11,010.
Insider Trading History of Lloyd A Rowland
- 1
Lloyd A Rowland Trading Performance
GuruFocus tracks the stock performance after each of Lloyd A Rowland's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lloyd A Rowland is -1.32%. GuruFocus also compares Lloyd A Rowland's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lloyd A Rowland within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lloyd A Rowland's insider trading performs compared to the benchmark.
Performance of Lloyd A Rowland
Average Return
-31.53%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.3 | -1.32 | -22.04 | -31.53 | -15.19 | -29.44 |
| Relative Return to S&P 500(%) | 2.2 | -1.69 | -27.23 | -43.57 | -31.33 | -45.15 |
Lloyd A Rowland Ownership Network
Ownership Network List of Lloyd A Rowland
Ownership Network Relation of Lloyd A Rowland
Lloyd A Rowland Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Lloyd A Rowland is the General Counsel of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Lloyd A Rowland made 4 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 16,868. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,235 shares made by Jeffrey B Landau , and a net sale of 20,991 shares made by Marcia Belvin .
In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Lloyd A Rowland Mailing Address
Above is the net worth, insider trading, and ownership report for Lloyd A Rowland. You might contact Lloyd A Rowland via mailing address: Amylin Pharmaceuticals Inc, 9360 Towne Centre Dr, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
